BusinessGalectin Therapeutics launches the Liver Line, an online community and publication on liver health and liver diseaseBy Nasdaq OMXMay 3, 2017, 12:31 PM UTC
BusinessGalectin Therapeutics launches the Liver Line, an online community and publication on liver health and liver diseaseBy Nasdaq OMXMay 3, 2017, 12:31 PM UTC
BusinessGalectin Therapeutics and Exalenz to Present Late-Breaking Abstract at The International Liver Congress™ 2017By Nasdaq OMXApr 18, 2017, 12:01 PM UTC
BusinessGalectin Therapeutics and Exalenz to Present Late-Breaking Abstract at The International Liver Congress™ 2017By Nasdaq OMXApr 18, 2017, 12:01 PM UTC
BusinessAssembly Biosciences to Present Data at The International Liver Congress(TM) 2016 that Supports Advancing Its CpAM Candidates into HBV Clinical TrialsBy Nasdaq OMXApr 13, 2016, 11:00 AM UTC
BusinessAssembly Biosciences to Present Data on New Series of HBV Core Protein Allosteric Modifiers at The International Liver Congress™ 2016By Nasdaq OMXMar 30, 2016, 11:30 AM UTC
